Guy Webber is a UK-based consultant specializing in DMPK, ADME, DDI, and early de-risking strategies, currently serving as the Director of Pre-Clinical Development at Phytanix Bio. With over 30 years of experience, they have held pivotal roles at GW Pharmaceuticals, Huntingdon Life Sciences, and Evotec, among others, where they managed complex cannabinoid studies, directed in vitro projects, and provided DMPK consultancy. Guy is also the founder of DMPK Services Ltd, offering comprehensive consulting in drug development and regulatory strategies. They hold a BSc and MSc in Chemistry and Medicinal Chemistry and Drug Metabolism from Loughborough University, continuing to advance research and development in drug metabolism and transport for innovative therapeutic solutions.
This person is not in the org chart
This person is not in any teams
This person is not in any offices